Michael Durante

25PUBLICATIONS
130CO-AUTHORS
Medical infection agents (incl. prions)Gene and molecular therapyMedical mycologyMolecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (25)

|Jan 02, 2026
Genomic mechanisms of resistance to venetoclax in multiple myeloma with t(11;14)(CCND1;IGH).

Marcella Kaddoura, J Erin Wiedmeier-Nutor, Vikas A Gupta

|Dec 19, 2025
Plasma cell identity escape drives resistance to anti-BCMA T-cell-redirecting therapy in multiple myeloma.

Francesco Maura, Ciara L Freeman, Kylee H Maclachlan

|Oct 08, 2025
Genomics Define Malignant Transformation in Myeloma Precursor Conditions.

Francesco Maura, P Leif Bergsagel, Bachisio Ziccheddu

|Sep 04, 2025
Timing Genomic Antigen Loss in Multiple Myeloma Treated with T Cell-Redirecting Immunotherapies.

Marios Papadimitriou, Sungwoo Ahn, Benjamin T Diamond

|Jun 30, 2025
Early Genetic Evolution of Driver Mutations in Uveal Melanoma.

James J Dollar, Christina L Decatur, Ezekiel Weis

|Jun 10, 2025
Biallelic antigen escape is a mechanism of resistance to anti-CD38 antibodies in multiple myeloma.

Benjamin Diamond, Linda Baughn, Mansour Poorebrahim

Pageof 5